Total Funding
12
Total FundingSeries A raised
Growth Score in past quarter
pts
Heat Score 12 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Carigent Therapeutics is a biotechnology company that develops therapeutic agents.
About the Company
Carigent Therapeutics is a biotechnology company that develops therapeutic agents. It offers a drug delivery platform for releasing therapeutic agents, targeting therapy to physiological sites, tethering surface ligands, and combining multiple agents. The company’s products are used in various applications such as genetic, systemic, and oncology
diseases.
Carigent Therapeutics was incorporated in 2006 and is based in New Haven, Connecticut, United States.
